NAMS — NewAmsterdam Pharma Company N.V. stock price, charts and financials

QT29NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
27.55
+0.06+0.22%
OverviewShort InterestFilings
NAMSQT29NewAmsterdam Pharma Company N.V.·NASDAQ
27.55+0.22%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 24, 20268-KCurrent report
Jul 22, 20268-KCurrent report
Jul 22, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 05, 2026S-8Registration of employee benefit securities
Jun 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 03, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 14, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 06, 2026DEF 14ADefinitive proxy statement
May 06, 2026ARSAnnual report to shareholders
Apr 24, 20268-KCurrent report
Apr 20, 2026PRE 14APreliminary proxy statement
Mar 12, 20264Statement of changes in beneficial ownership
Mar 10, 20264Statement of changes in beneficial ownership
Mar 09, 20264Statement of changes in beneficial ownership
Mar 02, 20268-KCurrent report
Mar 02, 20264Statement of changes in beneficial ownership
Feb 26, 20264Statement of changes in beneficial ownership
Feb 24, 20264Statement of changes in beneficial ownership
Feb 18, 20268-KCurrent report
Feb 18, 2026S-8Registration of employee benefit securities
#1 / 25 of 348
Page
▼
/ 14